Related Articles
lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity
SPRR3, a novel miR‑338‑3p target, regulates the malignant progression of clear cell renal cell carcinoma <em>in vitro</em> via the PI3K/Akt signaling pathway
miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2 Retraction in /10.3892/or.2022.8454
Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway
MicroRNA‑205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A